BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9223480)

  • 1. Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.
    Gulliver GA; Herber RL; Liem A; Lambert PF
    J Virol; 1997 Aug; 71(8):5905-14. PubMed ID: 9223480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.
    Herber R; Liem A; Pitot H; Lambert PF
    J Virol; 1996 Mar; 70(3):1873-81. PubMed ID: 8627712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo.
    Balsitis SJ; Sage J; Duensing S; Münger K; Jacks T; Lambert PF
    Mol Cell Biol; 2003 Dec; 23(24):9094-103. PubMed ID: 14645521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.
    Song S; Gulliver GA; Lambert PF
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2290-5. PubMed ID: 9482878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice.
    Lambert PF; Pan H; Pitot HC; Liem A; Jackson M; Griep AE
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5583-7. PubMed ID: 8390671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals.
    Song S; Pitot HC; Lambert PF
    J Virol; 1999 Jul; 73(7):5887-93. PubMed ID: 10364340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors.
    Auewarakul P; Gissmann L; Cid-Arregui A
    Mol Cell Biol; 1994 Dec; 14(12):8250-8. PubMed ID: 7969162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
    Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
    PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
    Pan H; Griep AE
    Genes Dev; 1994 Jun; 8(11):1285-99. PubMed ID: 7926731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation.
    Griep AE; Herber R; Jeon S; Lohse JK; Dubielzig RR; Lambert PF
    J Virol; 1993 Mar; 67(3):1373-84. PubMed ID: 8382301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.
    Balsitis S; Dick F; Lee D; Farrell L; Hyde RK; Griep AE; Dyson N; Lambert PF
    J Virol; 2005 Sep; 79(17):11392-402. PubMed ID: 16103190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16.
    Melero I; Singhal MC; McGowan P; Haugen HS; Blake J; Hellstrom KE; Yang G; Clegg CH; Chen L
    J Virol; 1997 May; 71(5):3998-4004. PubMed ID: 9094677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of lymphomagenic oncogenes in T-cell lymphomas of HPV 16 transgenic mice.
    Yang JT; Liu CZ; Domer P; Iannaccone P
    Cancer Detect Prev; 1998; 22(5):405-15. PubMed ID: 9727621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.
    Balsitis S; Dick F; Dyson N; Lambert PF
    Cancer Res; 2006 Oct; 66(19):9393-400. PubMed ID: 17018593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical/vaginal dysplasias of transgenic mice harbouring human papillomavirus type 16 E6-E7 genes.
    Sasagawa T; Kondoh G; Inoue M; Yutsudo M; Hakura A
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3057-65. PubMed ID: 7964615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
    von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
    J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human keratin 14 driven HPV 16 E6/E7 transgenic mice exhibit hyperkeratinosis.
    Kim SH; Kim KS; Lee EJ; Kim MO; Park JH; Cho KI; Imakawa K; Hyun BH; Chang KT; Lee HT; Ryoo ZY
    Life Sci; 2004 Nov; 75(25):3035-42. PubMed ID: 15474555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease.
    Frazer IH; Leippe DM; Dunn LA; Liem A; Tindle RW; Fernando GJ; Phelps WC; Lambert PF
    Cancer Res; 1995 Jun; 55(12):2635-9. PubMed ID: 7540107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.